Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

33.97
BATS BZX Real-Time Price
As of 12:56pm ET
 +0.015 / +0.04%
Today’s Change
25.55
Today|||52-Week Range
35.04
+24.32%
Year-to-Date
AstraZeneca Sells Marketing Rights to Seloken in Europe
11:04am / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Shows Strength: Stock Moves 9.2% Higher
May 15 / Zacks.com - Paid Partner Content
AstraZeneca PLC (AZN): Strong Industry, Solid Earnings Estimate Revisions
9:19am / Zacks.com - Paid Partner Content
What's in Store for Merck KGaA (MKGAF) in Q1 Earnings?
May 12 / Zacks.com - Paid Partner Content
AstraZeneca Shares Rise as Investors Shrug Off Mixed Diabetes Results
4:18am / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study
May 12 / Zacks.com - Paid Partner Content
Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab
May 22 / Zacks.com - Paid Partner Content
Trump does a China deal; Laptop ban; Retail pain
May 12 / CNNMoney.com
Clovis' (CLVS) PARP Inhibtor Shows Promise, Risks Remain
May 22 / Zacks.com - Paid Partner Content
Nektar Therapeutics (NKTR) Loss Wider Than Expected in Q1
May 11 / Zacks.com - Paid Partner Content
Endocyte (ECYT) Focused on Two Lead Pipeline Candidates
May 18 / Zacks.com - Paid Partner Content
Ironwood (IRWD) Q1 Loss Wider than Expected, Sales Miss
May 09 / Zacks.com - Paid Partner Content
AstraZeneca Imfinzi Positive in Phase III Lung Cancer Study
May 15 / Zacks.com - Paid Partner Content